PEPT — REX Peptide ETF

Data updated: 2026-10-09

PEPT — REX Peptide ETF. 0.65% expense ratio · since 2026 · Blend. Holdings, fees, performance and SEC filings.

PEPT Fund Overview

PEPT — REX Peptide ETF is a US ETF managed by REX ETF Trust, categorised as Blend. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

  • Type: US ETF
  • Manager: REX ETF Trust
  • Category: Blend
  • Ticker: PEPT
  • SEC CIK: 0002043954
  • SEC series ID: S000109823
  • Share class ID: C000280948

About PEPT

REX Peptide ETF (PEPT) seeks investment results that correspond generally to the price and yield, before fees and expenses, of the VettaFi Peptide Index. The Fund generally invests all or substantially all of its assets in the VettaFi Peptide Index's securities, which are equity securities of companies positioned to advance peptide-based products and enabling technologies. The Fund is non-diversified under the 1940 Act. Launched October 9, 2026, PEPT costs 0.65% a year.

PEPT Costs and Fees

PEPT costs about $65 per $10,000 invested per year in fund expenses.

  • Net expense ratio: 0.65%
  • Gross expense ratio: 0.65%

PEPT Debt Constituents

No individual debt constituents are reported in REX Peptide ETF's latest SEC N-PORT filing.

PEPT Prospectus and SEC Filings

Official REX Peptide ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

Related Funds

Other Blend funds tracked on ABC INVEST:

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.